retatrutide growth hormone (Triple-Action Jab): Phase III trial results published in The Lancet reveal that this triple-hormone receptor agonist (targeting GLP-1, GIP, and glucagon receptors) achieves unprecedented metabolic control. Over a 40-week trial of GLP-1 vs Retatrutide for Fat

Heres how we support you: Comprehensive assessment including hormone history, metabolic markers, and lifestyle review Personalized GLP-1 plan tailored dosing, scheduling, and support Regular check-ins monitor progress, adjust plan, ensure long-term results If youre ready to feel in control again, confident in your body, and supported through perimenopause, lets talk.

Research Square

We highlight mechanisms governing nutrient sensing and peptide secretion by enteroendocrine cells, including novel taste-like pathways

Medical Consultation Anyone taking prescription medications, particularly for blood sugar or metabolic conditions, should consult a doctor before starting ColonBroom

Millions of people are achieving meaningful results shedding 30, 50, even 80 pounds and experiencing life-changing shifts in their health and confidence